• Home
  • Search Results
  • The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.

The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.

PloS one (2015-04-01)
Mohamed Habib, Safaa Shaker, Nesreen El-Gayar, Sawsan Aboul-Fotouh
ABSTRACT

Several studies reveal that diabetes doubles the odds of comorbid depression with evidence of a pro-inflammatory state underlying its vascular complications. Indeed, little information is available about vascular effects of antidepressant drugs in diabetes. We investigated the effect of chronic administration of fluoxetine "FLU" and imipramine "IMIP" on behavioral, metabolic and vascular abnormalities in diabetic and non-diabetic rats exposed to chronic restraint stress (CRS). Both diabetes and CRS induced depressive-like behavior which was more prominent in diabetic/depressed rats; this was reversed by chronic treatment with FLU and IMIP in a comparable manner. Diabetic and non-diabetic rats exposed to CRS exhibited abnormalities in glucose homeostasis, lipid profile and vascular function, manifested by decreased endothelium-dependent relaxation, increased systolic blood pressure and histopathological atherosclerotic changes. Vascular and metabolic dysfunctions were associated with significant increase in aortic expression of TLR-4, and pro-inflammatory cytokines (TNF-α and IL-1ß). FLU ameliorated these metabolic, vascular and inflammatory abnormalities, while IMIP induced either no change or even worsening of some parameters. FLU has favorable effect over IMIP on metabolic, vascular and inflammatory aberrations associated with DM and CRS in Wistar rats, clarifying the preference of FLU over IMIP in management of comorbid depression in diabetic subjects.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sucrose, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
Streptozocin, ≥75% α-anomer basis, ≥98% (HPLC), powder
Sigma-Aldrich
Sucrose, ≥99.5% (GC)
Sigma-Aldrich
Sucrose, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
Sucrose, BioUltra, for molecular biology, ≥99.5% (HPLC)
Sigma-Aldrich
Sucrose, puriss., meets analytical specification of Ph. Eur., BP, NF
Sigma-Aldrich
Sucrose, ≥99.5%
Supelco
Sucrose, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Sucrose, ACS reagent
Millipore
Sucrose, suitable for microbiology, ACS reagent, ≥99.0%
Sigma-Aldrich
Sucrose, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99.5% (GC)
Sigma-Aldrich
Fluoxetine hydrochloride, solid
USP
Sucrose, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Corticosterone, ≥98.5% (HPLC)
Supelco
Fluoxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Sucrose, meets USP testing specifications
Supelco
Sucrose, analytical standard
Sigma-Aldrich
Corticosterone, ≥92%
Sigma-Aldrich
Imipramine hydrochloride, ≥99% (TLC)
Sigma-Aldrich
Sucrose, Grade II, suitable for plant cell culture
Sucrose, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Sucrose, Grade I, suitable for plant cell culture
Fluoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard
USP
Fluoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Supelco
Sucrose, analytical standard, for enzymatic assay kit SCA20
Supelco
Fluoxetine hydrochloride, VETRANAL®, analytical standard
Sigma-Aldrich
Imipramine hydrochloride, BioXtra, ≥99% (TLC)
Supelco
Corticosterone, VETRANAL®, analytical standard
Imipramine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Imipramine for system suitability, European Pharmacopoeia (EP) Reference Standard